DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20193121

A retrospective study on clinical and demographic features of autoimmune vesiculobullous disorders from a rural tertiary care institute in Tamil Nadu

Rajalakshmi Ramalingam, Vikram Kumar Adaikalam Ganapathy, Seethalakshmi Rajanga Chandrasekar, Balasubramanian Narasiman, Deivam Subbaraya Gounder

Abstract


Background: Autoimmune vesiculobullous disorders are a heterogenous group of skin diseases in which autoantibodies are directed against cell adhesion molecules which are essential for the integrity of skin and oral mucosa. They are clinically characterized by the presence of vesicles, bullae or erosions over the skin and/ or mucosa depending on the antibodies involved. They are divided into intraepidermal and subepidermal based on the location of the bulla. Among intraepidermal bullous disorders, pemphigus vulgaris (PV) is most common. Bullous pemphigoid (BP) is the most common among the subepidermal bullous disorders. Although they occur worldwide, the incidence shows geographical variation. A retrospective study was carried out with the objective to analyse the clinical and demographic profile of patients with autoimmune vesiculobullous disorders among patients attending a tertiary care teaching hospital in a rural setup.

Methods: A total of 137 case sheets were audited from the Medical Records Department of our institute. Details were collected and tabulated, compiled and analysed.

Results: Out of the 137 cases studied, intraepidermal autoimmune vesiculobullous disorders accounted for 63.4% of cases, and subepidermal autoimmune vesiculobullous disorders accounted for 36.6% of cases. Out of the 137 cases, 74 patients (54%) were females, and 63 patients (46%) were males. Majority of the patients were in the age group of 51-60 years (29.9%), followed by 41-50 years (24.1%) and 61-70 years (17.5%).

Conclusions: Pemphigus vulgaris was the most common among the intraepidermal autoimmune vesiculobullous disorders, and bullous pemphigoid was the most common among the subepidermal autoimmune vesiculobullous disorders.


Keywords


Pemphigus vulgaris, Bullous pemphigoid intraepidermal, Subepidermal

Full Text:

PDF

References


Johnston RB. Weedon’s Skin Pathology Essentials, 2nd Edition. Florida, USA: Elsevier; 2016.

Fatma S, Narla S, Jacob S, Geeth N. Correlation of Histology of Vesiculobullous Disorders With Immunofluorescence: A Study at A Tertiary Care Centre. National J Lab Med. 2018;7(4):28-33.

Taghipour K, Perera GK. Autoimmune blistering skin diseases. Medicine. 2013;41(7):387-93.

Nishie W. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII. J Dermatol Sci. 2014;73:179-86.

Pasricha JS. Pulse Therapy in Pemphigus and Other Diseases. 2nd edn. New Delhi: Pulse therapy & Pemphigus Foundation; 2000.

Huilgol SC, Bhogal BS, Black MM. Immunofl uorescence of the immunobullous disorders Part two: The clinical disorders. Indian J Dermatol Venereol Leprol. 1995;61:255-64.

Chhabra S, Minz RW, Saikia B. Immunofluorescence in dermatology. Indian J Dermatol Venereol Leprol. 2012;78:677-91.

Nanda A, Dvorak R, Al-Saeed K, Al-Sabah H, Alsaleh QA. Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol. 2004;43:876-81.

Deepti SP, Sulakshana MS, Manjunatha YA, Jayaprakash HT. A histomorphological study of bullous lesions of skin with special reference to immunofluorescence. Int J Curr Res Aca Rev. 2015;3:29-51.

Arya SR, Valand AG, Krishna K. A clinico-pathological study of 70 cases of pemphigus. Indian J Dermatol Venereol Leprol. 1999;65:168-71.

Mahajan VK, Sharma NL, Sharma RC, Garg G. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases. Int J Dermatol. 2005;44(10):821-7.

Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med. 2011;9:1.

Marzano AV, Tedeschi A, Spinelli D, Fanoni D, Crosti C, Cugno M. Coagulation activation in autoimmune bullous diseases. Clin Exp Immunol. 2009;158:31–6.

Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: Population based cohort study. BMJ. 2008;337:180.

Khandpur S, Verma P. Bullous pemphigoid. Indian J Dermatol Venereol Leprol. 2011;77:450-45.

De D, Khullar G, Handa S, Saikia UN, Radotra BD, Saikia B, et al. Clinical, demographic and immunopathological spectrum of subepidermal autoimmune bullous diseases at a tertiary center: A 1-year audit. Indian J Dermatol Venereol Leprol. 2016;82:358.

Wong SN, Chua SH. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: A 2-year review. Br J Dermatol. 2002;147:476-80.

Vinay K, Handa S, Khurana S, Agrawal S, De D. Dermatoscopy in Diagnosis of Cutaneous Myiasis Arising in Pemphigus Vulgaris Lesions. Indian J Dermatol. 2017;62(4):440.